Ato, Mac Steve .
HRN: 22-58-48 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2023
CEFUROXIME 750MG (VIAL)
02/10/2023
02/16/2023
IVT
470mg
Q8hrs
Epilepsy; Pcap B
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes